Write in a clean editor, then format for Journal of Market Access \& Health Policy in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Market Access \& Health Policy is a peer-reviewed journal published by MDPI, covering Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Economic and Financial Impacts of Cancer. Over its lifetime it has published 357 papers, which have received 5,234 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Journal of Market Access \& Health Policy 2023, 12, 45–58.
Formats any DOI in Journal of Market Access \& Health Policy style. No sign-up. |
| Abbreviation (ISO-4) | J. Mark. Access Health Policy |
| Publishes research in | Health Systems, Economic Evaluations, Quality of Life Pharmaceutical Economics and Policy Economic and Financial Impacts of Cancer Biomedical Ethics and Regulation Healthcare Policy and Management |
| ISSN | 2001-6689 |
| Citation impact (2-yr) | 2.1 |
| h-index | 37 |
| i10-index | 128 |
| Article processing charge | $1,459 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Aix-Marseille Université |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Vaccination has made an important contribution to the decreased incidence of numerous infectious diseases and associated mortality. In 2013, it was estimated that 103 million cases of childhood diseases in the United States had been prevented by the use of vaccines since 1924. These health effects translate into positive economic results, as vaccination can provide…
: Understanding drivers of biosimilar uptake becomes a critical issue to inform policy decision-makers. This study showed that incentive policies to enhance uptake remain an important driver of biosimilar penetration, while biosimilar price discounts have no impact. Future research is warranted when the biosimilar market gains maturity.
BACKGROUND: Advanced therapy medicinal products (ATMPs) are innovative therapies that encompass gene therapy, somatic cell therapy, and tissue-engineered products. These therapies are expected to bring important health benefits, but also to substantially impact the pharmaceuticals budget. OBJECTIVE: The aim of this study was to characterise the ATMPs in development and discuss future implications in terms…
Objective: To understand the different methodologies used to elicit willingness to pay for health and the value of a statistical life year through surveys.Methodology: A systematic review of the literature was undertaken to identify studies using surveys to estimate either willingness to pay for health or the value of a statistical life year. Each study…
Background: In 1989, the concept of human gene therapies has emerged with the first approved human gene therapy trial of Rosenberg et al. Gene therapies are considered as promising therapies applicable to a broad range of diseases.Objective: The objective of this study was to review the descriptive data on gene therapy clinical trials conducted worldwide…
